Credit: Shutterstock photoPharma giant Pfizer Inc. ( PFE ) caught an upgrade on Monday from analysts at SunTrust.
The firm boosted its rating on WSM from "Neutral" to "Buy" with a $40 price target. That new target represents a massive expected upside of 130% to the stock's Friday closing price of $17.42.
Pfizer shares rose 15 cents, or +0.9%, in premarket trading Monday.
The Bottom Line
Shares of PFE have a 4.13% dividend yield, based on Friday's closing stock price of $17.42. The stock has technical support in the $15-$17 price area. If the shares can firm up, we see overhead resistance around the $19-$20 price levels. We would remain on the sidelines for now.
Pfizer Inc. ( PFE ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.
Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Created by Dividend.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
